More importantly, we showed the inhibitory effect of vemurafenib in A549 cells, which do not carry the mutated BRAFV600E (14), further suggesting that enterovirus infection is not halted due to the inhibition of BRAF, but some other mechanism. The gene discussed is BRAF; the disease is enterovirus infectious disease.